The Significance of Plasma and/or Platelet Activated Products After Apheresis Procedures

• References

• 1 Stratta P, Canavese C, Peiretti F, Vallauri P, Vercellone A. Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor’s plasma units. Thromb Haemostas 1983; 49: 61
• 2 Sultan Y, Bussel A, Moissoneuve P, Poupeney M, Sitty X, Gaidos P. Potential danger of thrombosis after plasma, exchange in the treatment of patients with immune disease. Transfusion 1979; 19: 588-596
• 3 Belloni M, Fabris F, Ongaro G, Girolami A. Thrombosis after thrombopheresis. Transfusion 1981; 21: 229-230
• 4 Celia G, Vittadello O, Gallucci V, Girolami A. The release of beta- thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery. Eur J Clin Invest 1981; 11: 165-169
• 5 Maguire LC, Menriksen RA, Strauss RG, Goedken MM, Echtemacht B, Koeptke JA, Thompson JS. Platelet function in donors undergoing intermittent-flow centrifugation plateletpheresis or leukapheresis. Transfusion 1980; 20: 549-554
• 6 Fabris F, Belloni M, Casonato A, Randi M, Ongaro G, Girolami A. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombopheresis. Folia Haematol 1981; 108: 853-862
• 7 Underfriend S, Weissbach H, Clark CT. The estimation of 5- hydroxytriptamine (serotonin) in biological tissues. J Biol Chem 1955; 215: 337-344